Regenerative MedicineConverting Brain Cells Into Neurons Could Reverse Alzheimer's Damage
Current Alzheimer's drugs slow decline but cannot rebuild the neural circuits already destroyed by the disease. This review proposes a bold alternative: reprogramming the brain's own support cells — astrocytes — directly into functional neurons, in situ, without removing cells from the body. The authors outline a three-part strategy: first, clear the toxic inflammatory environment using senolytic drugs; second, use epigenetic tools like CRISPR-dCas9 to unlock dormant neuron-forming genes inside astrocytes; and third, deliver reprogramming factors using AI-designed lipid nanoparticles capable of crossing the blood-brain barrier. The approach also incorporates 'neurological digital twins' — personalized computational models — to time interventions optimally before symptoms worsen. This systems-level blueprint shifts the goal of Alzheimer's therapy from slowing loss to actively rebuilding brain structure.
